Descemet Membrane Versus Amniotic Membrane for Limbal Stem Cell Therapy

DM promotes LESC stemness better than AM in ex vivo culture and can support stratified corneal epithelium. DM is also a more transparent and potentially durable epithelial scaffold than AM. DM is a promising new alternative to AM for limbal stem cell therapy.

Authors

Institutions

Publication Details

Journal
Cornea
Published
2025-12-08
DOI
https://doi.org/10.1097/ico.0000000000004073
Primary Topic
Corneal Surgery and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Descemet Membrane Versus Amniotic Membrane for Limbal Stem Cell Therapy

Peter Bedard, Sung Lee, Heidi Roehrich, Joshua H. Hou et al.
Cornea
Corneal Surgery and Treatments
article

Descemet Membrane Versus Amniotic Membrane for Limbal Stem Cell Therapy

Peter Bedard, Sung Lee, Heidi Roehrich, Joshua H. Hou, Ching Yuan
article en

Abstract

DM promotes LESC stemness better than AM in ex vivo culture and can support stratified corneal epithelium. DM is also a more transparent and potentially durable epithelial scaffold than AM. DM is a promising new alternative to AM for limbal stem cell therapy.

Cornea
University of Minnesota (US), Minnesota Lions Eye Bank (US)
Openalex Percentile: Top 45%
Corneal Surgery and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.